Live Breaking News & Updates on Mast Therapeutics Inc

Stay updated with breaking news from Mast therapeutics inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Equities Analysts Offer Predictions for Savara Inc's Q1 2022 Earnings (NASDAQ:SVRA)

Savara Inc (NASDAQ:SVRA – Get Rating) – Equities researchers at Oppenheimer issued their Q1 2022 earnings per share estimates for Savara in a research note issued on Thursday, March 31st. Oppenheimer analyst F. Brisebois forecasts that the company will post earnings per share of ($0.08) for the quarter. Oppenheimer also issued estimates for Savara’s Q2 […] ....

Mast Therapeutics Inc , Goldman Sachs Group Inc , Life Insurance Co , Zacks Investment Research , Connor Clark Lunn Investment Management Ltd , Jpmorgan Chase Co , Savara Inc , Marquette Asset Management , Get Rating , Asset Management , Sachs Group , Connor Clark , Lunn Investment Management , Mast Therapeutics , Nasdaq Svra , Earnings Estimates , Oppenheimer Holdings Inc ,

Brokers Set Expectations for Savara Inc's Q1 2022 Earnings (NASDAQ:SVRA)

Savara Inc (NASDAQ:SVRA – Get Rating) – Equities researchers at Jefferies Financial Group issued their Q1 2022 EPS estimates for shares of Savara in a report released on Wednesday, March 30th. Jefferies Financial Group analyst S. Jeong forecasts that the company will post earnings per share of ($0.07) for the quarter. Jefferies Financial Group also […] ....

Mast Therapeutics Inc , Goldman Sachs Group Inc , Life Insurance Co , Renaissance Technologies , Connor Clark Lunn Investment Management Ltd , Jefferies Financial Group , Savara Company Profile Get Rating , Savara Inc , Millennium Management , Get Rating , Financial Group , Lunn Investment Management , Sachs Group , Company Profile , Mast Therapeutics , Nasdaq Svra , Earnings Estimates , Jefferies Financial Group Inc ,

Zacks: Analysts Expect Savara Inc (NASDAQ:SVRA) to Post -$0.07 EPS

Equities research analysts expect Savara Inc (NASDAQ:SVRA – Get Rating) to post ($0.07) earnings per share for the current quarter, according to Zacks. Zero analysts have made estimates for Savara’s earnings. The business is scheduled to report its next earnings report on Monday, January 1st. On average, analysts expect that Savara will report full-year earnings […] ....

Mast Therapeutics Inc , Goldman Sachs Group Inc , Life Insurance Co , Virtu Financial , Zacks Investment Research , Capital Management , Savara Company Profile Get Rating , Savara Inc , Marquette Asset Management , Get Rating , Asset Management , Goldman Sachs Group , Sachs Group , Company Profile , Mast Therapeutics , Nasdaq Svra ,

Goldman Sachs Group Inc. Has $236,000 Position in Savara Inc (NASDAQ:SVRA)

Goldman Sachs Group Inc. Has $236,000 Position in Savara Inc (NASDAQ:SVRA)
etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.

Badrula Chowdhury , Davida Ramsay , Mast Therapeutics Inc , Goldman Sachs Group Inc , Life Insurance Co , Zacks Investment Research , Savara Company Profile , Exchange Commission , Pricet Rowe Associates Inc , Squarepoint Ops , Ameriprise Financial Inc , Topco Ltd , Savara Inc , Goldman Sachs Group , Sachs Group , Director David , Mast Therapeutics , Visit Holdingschannel ,